The international big pharmaceutical companies involved in the vaccine production against Covid-19 earned more than 24.5 billion euros.
Novavax stock was off 2.6%, to $204.30, amid a flat market. The shares soared to nearly $330 in Feb, when it had begun filing with US FDA.
The company boosted full-year guidance on sales of its Covid-19 vaccine and said it is working to make the two-dose shot easier to administer and store.
mRNA COVID-19 vaccines are sailing along as viral vector shots encounter setback after setback. How will it affect vaccine sales in 2021?
Pfizer’s trial will include 4,000 pregnant women.
US pharma major Pfizer Inc expects to earn $15 billion, or about a quarter of its total revenue this year, from the sales of its COVID-19 vaccine.
The initial supplies from Pfizer and Moderna will be limited and reserved mainly for healthcare workers and nursing home patients.
The first doses of a Covid-19 vaccine are due to be rolled out in Jersey next week.